This web site was copied prior to January 20, 2005. It is now a Federal record managed by the National Archives and Records Administration. External links, forms, and search boxes may not function within this collection. Learn more.   [hide]
skip banner navigation
National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Quick Links
Cancer-related terms

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

NCI Calendar
Scientific meetings

Informacion en español
NCI Highlights
Chemo Extends Life in Advanced Prostate Cancer

Temozolomide Plus Radiation Helps Brain Cancer

Confirmed: Raloxifene Drops Risk of Breast Cancer

Bortezomib Delays Progression of Multiple Myeloma

Annual Report to the Nation

Past Highlights
Need Help?
Clinical Trials Clinical Trials Clinical Trials
Clinical Trials

Search for Clinical Trials Advanced Search | Help with this Form
Type of Cancer:
Type of Trial:
(Choose 1 or more)*
*Note: To choose multiple items:

a) PC Users - Hold Ctrl key and click on items

b) Mac Users - Hold Command key and click on items
Location of Trial: ZIP Code:        search within    
  ZIP Code Lookup
    NCI Clinical Trials at NIH Campus
Recent Developments



Testing & Screening

Patient Care Costs


Learning About Clinical Trials

Introduction to Clinical Trials

Educational Materials


Conducting Clinical Trials

Data & Safety Monitoring

List a Trial in NCI's PDQ®

Becoming a Co-Investigator


  Finding Clinical Trials

Ways to Find a Trial

Other Places to Look


Clinical Trial Results

Breast Cancer Trial Results

Colorectal Cancer Trial Results

Lung Cancer Trial Results


Clinical Trial Results
First Evidence That Chemotherapy Extends Life in Advanced Prostate Cancer [Posted: 6/7/2004]

Chemotherapy regimens that include the drug docetaxel extend median survival by two to three months in patients with advanced prostate cancer that is no longer responsive to hormone therapy, according to two phase III clinical trials whose findings were presented at the 2004 ASCO meeting in New Orleans.

See more Prostate Cancer Trial Results

Adding Chemotherapy to Radiation Increases Survival in Glioblastoma Multiforme [Posted: 6/7/2004]

Adding the drug temozolomide (Temodar®) to radiation therapy for the treatment of a brain tumor called glioblastoma multiforme increased survival in a large randomized trial. While this approach has been customary in the United States for several years, these findings are definitive and should establish this approach as the standard of care.

See more Brain Cancer Trial Results

NCI Cancer Bulletin

Featured Clinical Trials
Immunotherapy for Patients with Metastatic Melanoma

Comparison of Chemotherapy Combinations for Colon Cancer

More Featured Clinical Trials

skip footer navigation

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health